NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr |
What is the latest Total Debt ratio of NATCO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹363 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹404 Cr |
| Mar2021 | ₹266 Cr |
How is Total Debt of NATCO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | -24.81 | |
| Mar2024 | ₹363 Cr | 120.12 | |
| Mar2023 | ₹165 Cr | -59.16 | |
| Mar2022 | ₹404 Cr | 51.99 | |
| Mar2021 | ₹266 Cr | - | |
Compare Total Debt of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹18,256.6 Cr | 3.1% | 21.1% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.1% |
21.1% |
29.7% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses